Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3.6Revenue (TTM) $M5.5Net Margin (%)-259.7Altman Z-Score-41.5
Enterprise Value $M4.7EPS (TTM) $-7.8Operating Margin %-234.8Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-240.9Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %-45.1Quick Ratio2.1Cash flow > EarningsN
Price/Sales0.35-y EBITDA Growth Rate %-37.1Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-108.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-166.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4.9ROIC % (ttm)-389.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ROSG is held by these investors:



ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance Nov 18 2014 
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}
    FEEDBACK